ARCHIVES

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

ASCO Says FDA Plan For ESA Management Will Burden Oncologists

March 5, 2010

Congress Approves More Favorable Terms for Office-Administered Drugs

August 8, 1997

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

MIT’s Sharp To Head Biology Dept.; Hynes To Head Cancer Center

April 12, 1991